HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Patterson Selected Research
R Patterson Research Topics
Disease
3
Sudden Infant Death (SID)
04/2018 - 10/2016
2
Anaphylaxis (Anaphylactic Shock)
09/2001 - 05/2000
1
Carcinogenesis
09/2014
1
Prostatic Neoplasms (Prostate Cancer)
09/2014
1
Neoplasm Metastasis (Metastasis)
09/2014
1
Porcine Reproductive and Respiratory Syndrome (PRRS)
02/2011
1
Inflammation (Inflammations)
09/2008
1
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
09/2001
1
Phobic Disorders (Phobia)
09/2001
1
Neoplasms (Cancer)
05/2001
1
Hyperpigmentation
05/2001
1
Angioedema
03/2001
1
Serum Sickness
03/2001
1
Death (Near-Death Experience)
02/2001
1
Allergic Rhinitis
01/2001
1
Hypersensitivity (Allergy)
09/2000
1
Stevens-Johnson Syndrome (Lyell's Syndrome)
03/2000
1
Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
01/2000
1
Glutamate Monosodium Sensitivity
01/2000
Drug/Important Bio-Agent (IBA)
2
Amino Acids
FDA Link
04/2018 - 10/2016
2
Enzymes
IBA
12/2016 - 10/2016
2
Penicillins (Penicillin)
FDA Link
03/2001 - 09/2000
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2001 - 03/2000
1
Androgens
IBA
09/2014
1
Docetaxel (Taxotere)
FDA Link
09/2014
1
Phosphotransferases (Kinase)
IBA
09/2014
1
dendrotoxin A
IBA
09/2014
1
Messenger RNA (mRNA)
IBA
02/2011
1
Pathogen-Associated Molecular Pattern Molecules
IBA
02/2011
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
02/2011
1
Pattern Recognition Receptors
IBA
02/2011
1
Immunoglobulin A (IgA)
IBA
09/2008
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
09/2001
1
Lovastatin (Mevacor)
FDA Link
Generic
09/2001
1
Arsenic
IBA
05/2001
1
Prednisone (Sone)
FDA Link
Generic
03/2001
1
Nasal Decongestants (Decongestants)
IBA
01/2001
1
Cholinergic Antagonists (Anticholinergics)
IBA
01/2001
1
Histamine Antagonists (Antihistamines)
IBA
01/2001
1
Sodium Glutamate (Accent)
IBA
01/2000
1
Antigens
IBA
01/2000
Therapy/Procedure
4
Therapeutics
09/2001 - 03/2000
1
Immunotherapy
01/2001